Is Biora Therapeutics, Inc. (BIOR) a Buy, Sell, or Hold?
OTC : BIOR
Biora Therapeutics, Inc. — Institutional Ownership
$0.22 USD
$0 (0.0%)
- Volume
- 169.45K
- Average Volume
- 60.81K
- Market Capitalization
- $994.99K
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.38
- Year Low
- $0.15
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.30
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2025-08-04 | M.H. Davidson & Co. | 25624.0 | 0.56% |
| 2025-08-04 | TAGGETT MARGARET ELLEN | 297K | 6.60% |
| 2025-07-10 | Context Capital Management, LLC | 22025.0 | 0.50% |
| 2025-03-26 | Athyrium Opportunities Associates Co-Invest LLC | 2.5M | 36.50% |
| 2025-03-26 | Athyrium Opportunities Associates III LP | 919.79K | 13.40% |
| 2025-03-26 | Athyrium Opportunities III Acquisition 2 LP | 632.28K | 9.20% |
| 2025-03-26 | Athyrium Opportunities 2020 LP | 18333.0 | 0.30% |
| 2025-03-26 | Jeffrey A. Ferrell | 3.42M | 49.90% |
| 2025-03-26 | Athyrium Opportunities Associates III GP LLC | 919.79K | 13.40% |
| 2025-03-26 | Athyrium Funds GP Holdings LLC | 3.42M | 49.90% |
| 2025-03-26 | Athyrium Opportunities III Co-Invest 1 LP | 2.5M | 36.50% |
| 2025-03-26 | Athyrium Opportunities III Acquisition LP | 269.17K | 3.90% |
| 2024-11-14 | Highbridge Capital Management, LLC | 19.96M | 9.99% |
| 2024-08-20 | M.H. Davidson & Co. | 1.06M | 2.82% |
| 2024-08-20 | Anthony A. Yoseloff | 37.32M | 9.90% |
| 2024-08-20 | Davidson Kempner Arbitrage, Equities and Relative Value LP | 36.26M | 9.90% |
| 2024-08-20 | Davidson Kempner Capital Management LP | 37.32M | 9.90% |
| 2023-02-14 | Armistice Capital, LLC | 12.99M | 5.70% |
| 2023-02-14 | Steven Boyd | 12.99M | 5.70% |
| 2022-02-14 | Heights Capital Management, Inc. | 3.75M | 2.20% |
| 2022-02-14 | CVI Investments, Inc. | 3.75M | 2.20% |
| 2021-11-26 | Athyrium Opportunities 2020 LP | 4.58M | 2.10% |
| 2021-11-26 | Athyrium Opportunities III Acquisition LP | 7.26M | 3.40% |
| 2021-11-26 | Co-Invest | 27.36M | 12.70% |
| 2021-11-26 | Athyrium Opportunities Associates III LP | 39.77M | 18.40% |
| 2021-11-26 | Athyrium Opportunities Associates III GP LLC | 39.77M | 18.40% |
| 2021-11-26 | Jeffrey A. Ferrell | 67.13M | 31.10% |
| 2021-11-26 | Athyrium Opportunities III Acquisition 2 LP | 27.93M | 12.90% |
| 2021-11-26 | Athyrium Funds GP Holdings LLC | 67.13M | 31.10% |
| 2021-11-26 | Co-Invest | 27.36M | 12.70% |
| 2021-08-30 | CVI Investments, Inc. | 12.25M | 9.90% |
| 2021-08-30 | Heights Capital Management, Inc. | 12.25M | 9.90% |
| 2021-08-27 | Athyrium Opportunities III Acquisition 2 LP | 27.93M | 17.80% |
| 2021-08-27 | Athyrium Opportunities Fund (B) LP | 2.33M | 1.50% |
| 2021-08-27 | Athyrium Opportunities Fund (A) LP | 4.21M | 2.70% |
| 2021-08-27 | Athyrium Opportunities III Co-Invest 1 LP | 27.36M | 17.50% |
| 2021-08-27 | Athyrium Opportunities III Acquisition LP | 7.26M | 4.60% |
| 2021-08-27 | Athyrium Opportunities 2020 LP | 4.58M | 2.90% |
| 2021-08-27 | Athyrium Opportunities Associates LP | 6.54M | 4.20% |
| 2021-08-27 | Athyrium Opportunities Associates GP LLC | 6.54M | 4.20% |
| 2021-08-27 | Athyrium Capital Management, LP | 6.54M | 4.20% |
| 2021-08-27 | Athyrium Capital Holdings, LLC | 6.54M | 4.20% |
| 2021-08-27 | Jeffrey A. Ferrell | 73.67M | 47.00% |
| 2021-08-27 | Athyrium Opportunities Advisers LLC | 6.54M | 4.20% |
| 2021-08-27 | NB Alternatives Advisers LLC | 6.54M | 4.20% |
| 2021-08-27 | NB Alternatives GP Holdings LLC | 6.54M | 4.20% |
| 2021-08-27 | NB Alternatives Holdings LLC | 6.54M | 4.20% |
| 2021-08-27 | Co-Invest | 27.36M | 17.50% |
| 2021-08-27 | Athyrium Funds GP Holdings LLC | 67.13M | 42.80% |
| 2021-08-27 | Athyrium Opportunities Associates III LP | 39.77M | 25.40% |
| 2021-08-27 | Athyrium Opportunities Associates III GP LLC | 39.77M | 25.40% |
| 2021-06-21 | Athyrium Opportunities Fund (B) LP | 2.33M | 2.00% |
| 2021-06-21 | Athyrium Opportunities Fund (A) LP | 4.21M | 3.70% |
| 2021-06-21 | Athyrium Opportunities III Co-Invest 1 LP | 27.36M | 23.90% |
| 2021-06-21 | Athyrium Opportunities Associates III LP | 39.77M | 34.70% |
| 2021-06-21 | Athyrium Opportunities III Acquisition LP | 7.26M | 6.30% |
| 2021-06-21 | Athyrium Opportunities III Acquisition 2 LP | 27.93M | 24.30% |
| 2021-06-21 | Athyrium Opportunities 2020 LP | 4.58M | 4.00% |
| 2021-06-21 | Athyrium Opportunities Associates LP | 6.54M | 5.70% |
| 2021-06-21 | Athyrium Opportunities Associates GP LLC | 6.54M | 5.70% |
| 2021-06-21 | Athyrium Capital Management, LP | 6.54M | 5.70% |
| 2021-06-21 | Athyrium Capital Holdings, LLC | 6.54M | 5.70% |
| 2021-06-21 | Jeffrey A. Ferrell | 73.67M | 64.20% |
| 2021-06-21 | Athyrium Opportunities Advisers LLC | 6.54M | 5.70% |
| 2021-06-21 | NB Alternatives Advisers LLC | 6.54M | 5.70% |
| 2021-06-21 | NB Alternatives GP Holdings LLC | 6.54M | 5.70% |
| 2021-06-21 | NB Alternatives Holdings LLC | 6.54M | 5.70% |
| 2021-06-21 | Athyrium Opportunities Associates Co-Invest LLC | 27.36M | 23.90% |
| 2021-06-21 | Athyrium Funds GP Holdings LLC | 67.13M | 58.50% |
| 2021-06-21 | Athyrium Opportunities Associates III GP LLC | 39.77M | 34.70% |
| 2020-12-11 | Athyrium Funds GP Holdings LLC | 49.66M | 59.30% |
| 2020-12-11 | Co-Invest | 26.4M | 31.50% |
| 2020-12-11 | Athyrium Opportunities III Acquisition LP | 6.95M | 8.30% |
| 2020-12-11 | Athyrium Opportunities III Acquisition 2 LP | 11.73M | 14.00% |
| 2020-12-11 | Athyrium Opportunities 2020 LP | 4.58M | 5.50% |
| 2020-12-11 | Athyrium Opportunities Associates LP | 6.54M | 7.80% |
| 2020-12-11 | Athyrium Opportunities Associates GP LLC | 6.54M | 7.80% |
| 2020-12-11 | Athyrium Capital Management, LP | 6.54M | 7.80% |
| 2020-12-11 | Athyrium Capital Holdings, LLC | 6.54M | 7.80% |
| 2020-12-11 | Jeffrey A. Ferrell | 56.21M | 67.10% |
| 2020-12-11 | Athyrium Opportunities Advisers LLC | 6.54M | 7.80% |
| 2020-12-11 | NB Alternatives Advisers LLC | 6.54M | 7.80% |
| 2020-12-11 | NB Alternatives GP Holdings LLC | 6.54M | 7.80% |
| 2020-12-11 | NB Alternatives Holdings LLC | 6.54M | 7.80% |
| 2020-12-11 | Co-Invest | 26.4M | 31.50% |
| 2020-12-11 | Athyrium Opportunities Fund (A) LP | 4.21M | 5.00% |
| 2020-12-11 | Athyrium Opportunities Fund (B) LP | 2.33M | 2.80% |
| 2020-12-11 | Athyrium Opportunities Associates III LP | 23.27M | 27.80% |
| 2020-12-11 | Athyrium Opportunities Associates III GP LLC | 23.27M | 27.80% |
| 2020-07-06 | Athyrium Funds GP Holdings LLC | 16.76M | 35.80% |
| 2020-07-06 | NB Alternatives GP Holdings LLC | 6.54M | 14.00% |
| 2020-07-06 | Jeffrey A. Ferrell | 23.3M | 49.80% |
| 2020-07-06 | NB Alternatives Advisers LLC | 6.54M | 14.00% |
| 2020-07-06 | Athyrium Capital Holdings, LLC | 6.54M | 14.00% |
| 2020-07-06 | Athyrium Opportunities Associates LP | 6.54M | 14.00% |
| 2020-07-06 | Athyrium Opportunities Fund (B) LP | 2.33M | 5.00% |
| 2020-07-06 | Athyrium Capital Management, LP | 6.54M | 14.00% |
| 2020-07-06 | Athyrium Opportunities Associates GP LLC | 6.54M | 14.00% |
| 2020-07-06 | Athyrium Opportunities 2020 LP | 4.58M | 9.80% |
| 2020-07-06 | Athyrium Opportunities III Acquisition 2 LP | 7.6M | 16.20% |
| 2020-07-06 | Co-Invest | 4.58M | 9.80% |
| 2020-07-06 | Athyrium Opportunities Associates III GP LLC | 12.19M | 26.00% |
| 2020-07-06 | Athyrium Opportunities Associates III LP | 12.19M | 26.00% |
| 2020-07-06 | Co-Invest | 4.58M | 9.80% |
| 2020-07-06 | Athyrium Opportunities Advisers LLC | 6.54M | 14.00% |
| 2020-07-06 | NB Alternatives Holdings LLC | 6.54M | 14.00% |
| 2020-07-06 | Athyrium Opportunities Fund (A) LP | 4.21M | 9.00% |
| 2020-07-02 | Harry Stylli, Ph.D. | 14.23M | 31.50% |
BIOR Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2023-12-31 | $13.50 | 1.58M | $21.29M | $15.21M | $47.43M | $53.51M |
| 2022-12-31 | $32.92 | 763.51K | $25.13M | $30.49M | $129.3M | $123.95M |
| 2021-12-31 | $522.50 | 384.62K | $200.96M | $88.4M | $126.4M | $238.97M |
| 2020-12-31 | $1327.50 | 223.09K | $296.15M | $92.08M | $160.54M | $364.62M |
| 2019-12-31 | $3280.00 | 184.66K | $605.67M | $33.04M | $73.37M | $646M |
| 2018-12-31 | $3280.00 | 107.84K | $353.73M | $49M | $72.74M | $377.46M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2024-09-30 | $5.02 | 3.65M | $18.34M | $3.2M | $39.65M | $54.79M |
| 2024-06-30 | $6.30 | 3.65M | $23.01M | $5.32M | $46.96M | $64.65M |
| 2024-03-31 | $7.35 | 2.93M | $21.53M | $10.82M | $46.76M | $57.47M |
| 2023-12-31 | $13.50 | 2.48M | $33.49M | $15.21M | $47.43M | $65.71M |
| 2023-09-30 | $21.70 | 1.5M | $32.6M | $12.57M | $82.39M | $102.43M |
| 2023-06-30 | $38.50 | 1.21M | $46.75M | $26.45M | $130.5M | $150.8M |
| 2023-03-31 | $27.70 | 1.1M | $30.39M | $30.46M | $130.4M | $130.33M |
| 2022-12-31 | $32.92 | 834.98K | $27.49M | $30.49M | $129.3M | $126.31M |
| 2022-09-30 | $121.23 | 747.81K | $90.66M | $37.06M | $129.33M | $182.92M |
| 2022-06-30 | $175.00 | 737.49K | $129.06M | $48.51M | $129.23M | $209.79M |
| 2022-03-31 | $290.00 | 732.81K | $212.51M | $67.23M | $129.26M | $274.54M |
| 2021-12-31 | $522.50 | 664.29K | $347.09M | $88.4M | $126.4M | $385.1M |